Josef Priller1,2,3, Marco Prinz4,5,6. 1. Department of Neuropsychiatry, Charité and BIH, Berlin, Germany. josef.priller@charite.de marco.prinz@uniklinik-freiburg.de. 2. DZNE, Berlin, Germany. 3. University of Edinburgh and UK DRI, Edinburgh, UK. 4. Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany. josef.priller@charite.de marco.prinz@uniklinik-freiburg.de. 5. Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany. 6. Center for Basics in NeuroModulation, Freiburg, Germany.
Authors: Takahiro Masuda; Lukas Amann; Roman Sankowski; Ori Staszewski; Maximilian Lenz; Paolo D Errico; Nicolas Snaidero; Marta Joana Costa Jordão; Chotima Böttcher; Katrin Kierdorf; Steffen Jung; Josef Priller; Thomas Misgeld; Andreas Vlachos; Melanie Meyer-Luehmann; Klaus-Peter Knobeloch; Marco Prinz Journal: Nat Immunol Date: 2020-06-15 Impact factor: 25.606